Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior in persons...
Vous n'êtes pas connecté
FRIDAY, Aug. 23, 2024 -- Low-grade systemic inflammation across childhood and adolescence is associated with the subsequent onset of mental health disorders, according to a study published online Aug. 21 in JAMA Psychiatry. Edward R. Palmer...
Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior in persons...
Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior in persons...
In the complex landscape of mental health research, a new peer-reviewed Viewpoint review sheds light on an underexplored genetic player: the trace...
WEDNESDAY, Sept. 11, 2024 -- A history of upper gastrointestinal mucosal damage (MD) is associated with a higher subsequent risk for developing...
WEDNESDAY, Sept. 11, 2024 -- Exposure to systemic glucocorticoids during hospitalization is associated with an increased risk for new-onset diabetes,...
FRIDAY, Sept. 6, 2024 -- Exposure to outdoor nighttime light is associated with the prevalence of Alzheimer disease (AD), especially among those aged...
FRIDAY, Sept. 13, 2024 -- Smoking cessation is associated with a reduced risk for atrial fibrillation (AF), according to a study published online...
WEDNESDAY, Sept. 4, 2024 -- First-generation antihistamines are associated with a higher seizure risk in young children, according to a study...
MONDAY, Sept. 9, 2024 -- Insulin resistance (IR) is associated with multiple systemic diseases, according a study presented at the annual meeting of...
Learn how systemic glucocorticoids, used for treating inflammatory conditions, are linked to a significantly higher risk of new-onset diabetes.